cAMP detection methods in HTS: Selecting the best from the rest

Nature Reviews Drug Discovery

Volumn 3, Issue 2, 2004, Pages 125-135

  Williams, Christine ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; LUCIFERASE;

BIOTECHNOLOGY; CELL ASSAY; CHEMOLUMINESCENCE; ENZYME ANALYSIS; FLUORESCENCE POLARIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE AMPLIFICATION; GENETIC ANALYSIS; IN VITRO STUDY; LUMINESCENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; RADIOMETRY; RECEPTOR UPREGULATION; REPORTER GENE; REVIEW; SIGNAL TRANSDUCTION; THEORY; TISSUE CULTURE;

EID: 1242308248     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1306     Document Type: Review

References (65)

1. Langley, J. N. On nerve endings and on special excitable substances in cells. Proc. Roy. Soc. B78, 170-194 (1906).
2. Ehrlich, P. Chemotherapeutics: scientific principles, methods and results. Lancet 2, 445-451 (1913).
3. Bleicher, K. H. et al. Hit and lead generation: beyond high-throughput screening. Nature Rev. Drug Disc. 2, 369-378 (2003).
4. Hopkins, A. L. & Groom, C. R. The druggable genome. Nature Rev. Drug. Disc. 1, 727-730 (2002).
5. Sittampalam, G. S. et al. High-throughput screening: advances in assay technologies. Curr. Opin. Chem. Biol. 13, 384-391 (1997).
6. Hemmila, I. A. & Hurskainen, P. Novel detection strategies for drug discovery. Drug Disc. Today 7, S150-S156 (2002).
7. Walters, W. P. & Namchuk, M. Designing screens: how to make your hits a hit. Nature Rev. Drug. Disc. 2, 259-266 (2003).
8. Croston, G. E. Functional cell-based uHTS in chemical genomic drug discovery. Trends Biotech. 20, 110-115 (2002).
9. Hertzberg, R. P. & Pope, A. J. High-throughput screening: new technology for the 21st century. Curr. Opin. Chem. Biol. 4, 445-451 (2000).
10. Johnston, P. A. & Johnston, P. A. Cellular platforms for HTS: three case studies. Drug Disc. Today 7, 353-363 (2002).
11. Christopoulos, A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nature Rev. Drug Disc. 1, 198-210 (2002).
12. Kenakin, T. Pharmacological Analysis of Drug-Receptor Interaction 3rd edn (Lippincott-Raven, Philadelphia, 1997).
13. Hanoune, J. & Defer, N. Regulation and role of adenylyl cyclase isoforms. Annu. Rev. Pharmacol. Toxicol. 41, 145-174 (2001).
14. Patel, T. B. et al. Molecular biological approaches to unravel adenylyl cyclase sugnaling and function. Gene 269, 13-25 (2001).
15. Thompson, W. J. Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. Pharmacol. Ther. 51, 13-33 (1991).
16. Amersham Life Science. High throughput screening for cAMP formation by scintillation proximity radioimmunoassay. Proximity News Issue No. 23. (1996).
17. NEN Life Science Products. A novel adenylyl cyclase activation assay on FlashPlate (Flasplate File #1, Application Note). NEN Life Science Products Inc., Boston, Massachusetts, 1998).
18. Kariv, I. I. et al. High throughput quantitation of cAMP production mediated by activation of seven transmembrane domain receptors. J. Biomol. Screen. 4, 27-32 (1999).
19. Prystay L. et al. Homogeneous cell-based fluorescence polarisation assay for the direct detection of cAMP. J. Biomol. Screen. 6, 75-82 (2001).
20. s-coupled receptors in membranes. J. Biomol. Screen. 7, 35-44 (2002).
21. Banks, P. et al. Impact of a red-shifted dye label for high throughput fluorescence polarisation assays of G-protein coupled receptors. J. Biomol. Screen. 5, 329-334 (2000).
22. Packard Bioscience. Whole cell cAMP Functional Assay (Technical Note, AN002 ASc). (Packard Instrument Company, Meriden, Connecticut, 2000).
23. Bouchard, N. et al. cAMP alphascreen assay: a method for the pharmacological characterization and screening of Gαl-coupled receptors in whole cells. (Perkin Elmer, Montreal, Canada, 2002).
24. Colla, R. & Seethala, R. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists. J. Biomol. Screen. 7, 515-525 (2002).
25. Packard Bioscience. Analysis of potential compound interference of ALPHAScreen Signal (Application Note, ASC-012). (Packard Bioscience Company Inc., Meriden, Connecticut, 2001).
26. Chiulli, A. C. et al. A novel high throughput chemiluminescent assay for the measurement of cellular cyclic adenosine monophosphate levels. J. Biomol. Screen. 5, 239-247 (2000).
27. Scott, M. G. H. et al. Effects of a range of β2-adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells. Br. J. Pharmacol. 128, 721-729 (1999).
28. Hill, S. J. et al. Reporter-gene systems for the study of G-protein-coupled receptors. Curr. Opin. Pharmacol. 1, 526-532 (2001).
29. Wood, K. V. Marker proteins for gene expression. Curr. Opin. Biotechnol. 6, 50-58 (1995).
30. Southward, C. M. & Surett, M. G. The dynamic microbe: green fluorescent protein brings bacteria to light. Mol. Microbiol. 45, 1191-1196 (2002).
31. Greer, L. F. & Szalay, A. A. Imaging of light emission from the expression of luciferases in living cells and organisms: a review. Luminescence 17, 43-74 (2002).
32. i-protein coupled receptors. Mol. Biotechnol. 21, 9-18 (2002).
33. q coupled signalling pathways. Anal. Biochem. 226, 349-354 (1995).
34. Stables, J. et al. Development of a dual glow-signal firefly and Renilla luciferase reagent for the analysis of G-protein coupled receptor signalling. J. Recept. Signal Tansduct. Res. 19, 395-410 (1999).
35. Vivian, V. R. The origin, diversity and structure function relationships of luciferases. Cell. Mol. Life Sci. 59, 1833-1850 (2002).
36. Zlokarnik, G. et al. Quantitation of transcription and clonal selection of single living cells with β-lactamase as reporter. Science 279, 84-88 (1998).
37. Kanupoli, P. et al. Development of an intact cell reporter gene β-lactamase assay for G protein-coupled receptors for high-throughput screening. Anal. Biochem. 314, 16-29 (2003).
38. Knapp, T. et al. Detection of β-lactamase reporter gene expression by flow cytometry. Cytometry 51A, 68-78 (2003).
39. Whitney, M. et al. A genome-wide functional assay of signal transduction in living mammalian cells. Nature Biotech, 16, 1329-1333 (1998).
40. George, S. E. Evaluation of a CRE-directed luciferase reporter gene assay as an alternative to measuring cAMP accumulation. J. Biomol. Screen. 2, 235-240 (1997).
41. Goetz, A. S. et al. Development of a facile method for high throughput screening with reporter gene assays. J. Biomol. Screen. 5, 377-384 (2000).
42. Kemp, D. M. et al. The effect of ICER on screening methods involving CRE-mediated reporter gene expression. J. Biomol. Screen. 7, 141-148 (2002).
43. Kemp, D. M. et al. Partial agonism at serotonin 5-HT1B and dopamine D2L receptors using a luciferase reporter gene assay. Eur. J. Pharmacol. 373, 215-222 (1999).
44. Terstappen, G. C. et al. Development of a functional reporter gene HTS assay for the identification of mGluR7 modulators. J. Biomol. Screen. 5, 255-261 (2000).
45. Baker, J. et al. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses. Mol. Pharmacol. 64, 679-688 (2003).
46. Nagmani, R. Evaluation of beta-adrenergic receptor subtypes in the human prostate cancer cell line-LNCaP. Biochem. Pharmacol. 65, 1489-1494 (2003).
47. Zhang, J. et al. A simple statistical parameter for use in evaluation and validation of high thoughput screening assays. J. Biomol. Screen. 4, 67-73 (1999).
48. Offermans, S. & Simon, M. I. Gα15 and Gα16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem. 270, 15175-15180 (1995).
49. Conklin, B. R. et al. Carboxy-terminal mutations of Gqα and Gsα that alter the fidelity of receptor activation. Mol. Pharmacol. 50, 885-890 (1996).
50. Milligan, G. & Rees, S. Chimeric Gα proteins: their potential use in drug discovery. Trends Pharmacol. Sci. 20, 118-124 (1999).
51. Kostenis, E. Is Gα16 the optimal tool for fishing ligands of orphan G-protein-couped receptors? Trends Pharmacol. Sci. 22, 560-564 (2001).
52. Craig, D. The Cheng-Prussoff relationship:something lost in the translation. Trends Pharmacol. Sci. 14, 89-91 (1993).
53. Leff, P. & Dougall, G. Further concerns over Cheng-Prusoff analysis. Trends Pharmacol. Sci. 14, 110-112 (1993).
54. Giuliano, K. A. High-content profiling of drug-drug interactions: cellular targets involved in modulation of microtubule drug action by the antifungal ketoconazole. J. Biomol. Screen. 8, 125-135 (2003).
55. Angers, S. et al. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl Acad. Sci. USA 97, 3684-3689 (2000).
56. Conway, B. R. et al. Quantification of G-protein coupled receptor internalisation using G-protein coupled receptor-green fluorescent protein conjugates with the ArrayScan TM High-content screening system. J. Biomol. Screen. 4, 75-86 (1999).
57. Barak, L. S. et al. A β-arrestin/green fluorescent protein biosensor for detecting G-protein coupled receptor activation. J. Biol. Chem. 272, 27497-27500 (1997).
58. Hermans, E. Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol. Ther. 99, 25-44 (2003).
59. Goetz, A. S. et al. A combination assay for simultaneous assessment of multiple signalling pathways. J. Pharmacol. Toxicol. Methods 42, 225-235 (1999).
60. Meyer, T. & Teruel, M. N. Fluorescence imaging of signalling networks. Trends Cell Biol. 13, 101-106 (2003).
61. Hurskainen, P. et al. Time-resolved fluoremetry in bioanalytical assays. Chem. Today 5, 22-24 (2001).
62. 35S]GTPγS binding assays. Trends Pharmacol. Sci. 24, 87-90 (2003).
63. 2+ mobilization in the apparent absence of inositol 1,4,5-triphosphate 3-kinase activity. J. Biol. Chem. 263, 15297-15303 (1988).
64. Chambers, C. et al. Measuring intracellular calcium fluxes in high throughput mode. Comb. Chem. & High Throughput Screen. 6, 355-362 (2003).
65. Schroeder, K. S. & Neagle, B. D. FLIPR: a new instrument for accurate, high throughput optical screening. J. Biomol. Screen. 1, 75-80 (1996).